Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Paraneoplastic Syndromes × gamma-Globulins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 5 Neoplasms, Plasma Cell 4 Lymphoma 4 Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Infections 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Congenital Abnormalities 2 Sezary Syndrome 1 Primary Myelofibrosis 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Paraneoplastic Syndromes 1 Neuroblastoma 1 Mycosis Fungoides 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

gamma-Globulins 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06373211 2025-02-17

NESPA

Assistance Publique - Hôpitaux de Paris

Phase 2 Recruiting

Paraneoplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡